E. Wolfrom et al., CHRONIC URTICARIA AND TOXOCARA-CANIS INFE CTION - A CASE-CONTROL STUDY, Annales de dermatologie et de venereologie, 123(4), 1996, pp. 240-246
Introduction. The cause of chronic urticaria remains unknown very ofte
n. Having noted several cases of chronic urticaria associated with ant
ibodies to Toxocara canis, and lacking any other explanation, we set-u
p a case-control study. Patients and methods. Between November 1992 an
d April 1993, 51 adults or children with chronic urticaria (cases) who
had been examined al least once at one of the three dermatology units
of the Bordeaux University Hospital were matched to controls who had
neither signs nor symptoms of chronic urticaria. The presence of antib
odies to T. canis was measured by ELISA and Western blot. Results. The
frequency of T. canis was 64.7 p. 100 in cases and 21 p. 100 in contr
ols (p < 0.0001) with an odds ratio of 6.9 (95 p. 100 CI: 2.9-16.3). C
ases with antibodies to T. canis were more frequently in contact with
pets (84 vs 50 p. 100, p < 0.001). Of the 33 cases of chronic urticari
a with antibodies to T. canis, 14 have been treated with thiabendazole
or ivermectin and after a one-year follow-up, 5 (36 p. 100) were cure
d and 4 (29 p. 100) had improvement. No improvement occurred in the 12
/19 cases not specifically treated. Conclusion. The strong association
between the presence of antibodies to Toxocara canis and chronic urti
caria is unlikely to be due to chance. A causal relation is difficult
to establish, however. Our findings should prompt further investigatio
n of a role for Toxocara canis in chronic urticaria and the evaluation
of therapeutic interventions. Preventive measures include deworming p
ets (dogs particularly), enclosing kitchen gardens, and handwashing be
fore meals. A systematic measure of Toxocara canis in patients with ch
ronic urticaria is recommended especially when in contact with dogs. E
arly and specific treatments can be applied on knowledge we already ha
ve.